BRVE today
$18.60+$1.19 (+6.80%)close Nov 6, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourBullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $22.51
Key levels
Resistance$22.22
Resistance$20.00
Support$18.00
Latest news & SEC filings
ProductHRS/BHB-1893 shows 52-week benefit in oHCM, two drugmakers say
All BRVE news →Nasdaq · Healthcare
Braveheart Bio, Inc. (BRVE)
What Is the Price Target for BRVE?
SEPT Low Target
$38.25
SEPT Mid Target
$45.00
SEPT High Target
$51.75
Analyst Consensus
$45.00
Is BRVE a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BRVE.
Start Free Trial →Is BRVE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$45.00
5
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with BRVE?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BRVE Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for BRVE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BRVE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:24:44 | $18.23 | 1,099 | $$20K | SELL |
| 19:59:37 | $18.50 | 1,300 | $$24K | MIDPOINT |
| 17:05:18 | $17.96 | 1,000 | $$18K | BUY |
| 17:05:11 | $17.96 | 3,451 | $$62K | BUY |
| 17:05:03 | $17.95 | 25,100 | $$451K | SELL |
5 dark pool trades shown · $$575K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Braveheart Bio, Inc. (BRVE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BRVE — frequently asked questions
What is BRVE stock price today?
Braveheart Bio, Inc. (BRVE) is at $18.60, up 6.80% (+$1.19) at the Nov 6, 2026 close.
Why is BRVE stock moving today?
Latest BRVE news — Nov 6, 2026: HRS/BHB-1893 shows 52-week benefit in oHCM, two drugmakers say
What is the BRVE price target?
The average analyst price target for BRVE is $45.00, ranging from $40 to $48, based on 5 analysts.
What do analysts rate BRVE?
Analyst ratings for BRVE: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did BRVE beat earnings?
BRVE last reported on Sep 8, 2026: EPS -$2.51 vs $2.69 expected — a miss of 193.3%.
What are BRVE support and resistance levels?
Support: $18.00. Resistance: $20.00, $22.22, $24.30.
What are insiders doing with BRVE?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BRVE?
Nov 6, 2026: HRS/BHB-1893 shows 52-week benefit in oHCM, two drugmakers say